WEISBLUM ERIC (CHIEF EXECUTIVE OFFICER) purchased 0.4% of their position (650.00 shares) of SILO PHARMA, INC. on the open market
Open‑market purchase worth $1.1K — a small addition. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 11/27/2023ACC: 0001213900-23-090270
DirectorOfficer· CHIEF EXECUTIVE OFFICER
Since Apr 2020
+650.00
Net shares
Net buyer
$1.1K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
650.00 acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+400.00
Price / share
$1.68
Trade value
$672.00
% of position
0.2%
11/22/2023
164.47K→164.87K
Common Stock
Direct
Shares
+250.00
Price / share
$1.78
Trade value
$445.00
% of position
0.2%
11/27/2023
164.87K→165.12K
Total
Net shares
+650.00
Net value
$1.12K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/22/2023 | P · Purchase | +400.00 | $1.68 | $672.00 | 0.2% | 164.47K | 164.87K |
| Common Stock Direct | 11/27/2023 | P · Purchase | +250.00 | $1.78 | $445.00 | 0.2% | 164.87K | 165.12K |
| Total | +650.00 | $1.12K | ||||||
Derivative Transactions0
No derivative transactions reported